- Home
- ABEV vs A Comparison
ABEV vs A Comparison
Compare ABEV & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEV
- A
- Stock Information
- Founded
- ABEV 1885
- A 1999
- Country
- ABEV Brazil
- A United States
- Employees
- ABEV N/A
- A N/A
- Industry
- ABEV Beverages (Production/Distribution)
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- ABEV Consumer Staples
- A Industrials
- Exchange
- ABEV Nasdaq
- A Nasdaq
- Market Cap
- ABEV 34.8B
- A 29.3B
- IPO Year
- ABEV N/A
- A 1999
- Fundamental
- Price
- ABEV $2.40
- A $102.48
- Analyst Decision
- ABEV Hold
- A Buy
- Analyst Count
- ABEV 2
- A 13
- Target Price
- ABEV $2.00
- A $147.33
- AVG Volume (30 Days)
- ABEV 32.7M
- A 2.7M
- Earning Date
- ABEV 05-08-2025
- A 05-28-2025
- Dividend Yield
- ABEV 0.93%
- A 0.97%
- EPS Growth
- ABEV N/A
- A 4.31
- EPS
- ABEV 0.15
- A 4.36
- Revenue
- ABEV $14,463,074,459.00
- A $6,533,000,000.00
- Revenue This Year
- ABEV $7.90
- A $5.55
- Revenue Next Year
- ABEV $5.47
- A $6.07
- P/E Ratio
- ABEV $16.04
- A $23.51
- Revenue Growth
- ABEV 12.19
- A N/A
- 52 Week Low
- ABEV $1.76
- A $96.43
- 52 Week High
- ABEV $2.56
- A $155.35
- Technical
- Relative Strength Index (RSI)
- ABEV 61.28
- A 35.47
- Support Level
- ABEV $2.26
- A $96.43
- Resistance Level
- ABEV $2.32
- A $106.21
- Average True Range (ATR)
- ABEV 0.08
- A 5.10
- MACD
- ABEV -0.00
- A 0.03
- Stochastic Oscillator
- ABEV 78.79
- A 28.40
About ABEV Ambev S.A.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.